The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...
Gerdau S/A Ord-0.05% R$41.48B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback